Source: April 27, 2016 10:40 AM Eastern Daylight Time FRANKFURT AM MAIN & BOSTON--(BUSINESS WIRE)--Merz Pharma has made a strategic venture investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat sagging skin associated with aging. Merz has joined a growing set of…...